Advanced Cell Diagnostics' Series A Round

Advanced Cell Diagnostics raised a round of funding on September 21, 2009. Investors include Morningside Group (晨兴集团).

Advanced Cell Diagnostics (ACD) is a provider in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. The company's products and ser…

Articles about Advanced Cell Diagnostics' Series A Round: